Molecular targeted therapy market to reach $107.64 billion by 2030 at 8.4% CAGR, driven by rise of personalized medicine.
Read MoreModular fill-finish micro-factory market to reach $2.96 billion by 2030 at 11.1% CAGR, driven by increasing demand for personalized medicines.
Read MoreMinimal residual disease testing market to reach $3.31 billion by 2030 at 13.1% CAGR, driven by increasing prevalence of cancer.
Read MoreMineral supplements market to reach $24.28 billion by 2030 at 6.3% CAGR, driven by increased sports and fitness activities.
Read MoreMilk protein concentrate market to reach $4.25 billion by 2030 at 6.9% CAGR, driven by rising demand for high-protein foods.
Read MoreThe global migraine drugs market to reach $7.47 billion by 2030 at 5.5% CAGR, driven by increase in prevalence of migraine.
Read MoreMid-size pharmaceuticals market to reach $1059.05 billion by 2030 at 7.0% CAGR, driven by increased prevalence of chronic diseases.
Read MoreMicrotubule inhibitor chemotherapy drugs market to reach $7.23 billion by 2030 at 5.8% CAGR, driven by increasing prevalence of cancer.
Read MoreMicrocarrier beads market to reach $4.95 billion by 2030 at 8.9% CAGR, driven by growing trend of personalized medicine.
Read MoreNon-hormonal contraceptives market to reach $35.8 billion by 2030 at 7.0% cagr, driven by growing prevalence of sexually transmitted diseases.
Read More